{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:58:03Z","timestamp":1793177883466,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Potentials Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is the most common form of primordial dwarfism, caused by bialleic mutations in the pericentrin gene (<jats:italic>PCNT<\/jats:italic>). Aside from its classic features, there are multiple associated medical complications, including a well-documented risk of neurovascular disease. Over the past several years, it has become apparent that additional vascular issues, as well as systemic hypertension and kidney disease may also be related to MOPDII. However, the frequency and extent of the vasculopathy was unclear. To help address this question, a vascular substudy was initiated within our Primordial Dwarfism Registry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Medical records from 47 individuals, living and deceased, ranging in age from 3 to 41\u00a0years of age were interrogated for this purpose. Of the total group, 64% were diagnosed with moyamoya, intracranial aneurysms, or both. In general, the age at diagnosis for moyamoya was younger than aneurysms, but the risk for neurovascular disease was throughout the shortened lifespan. In addition to neurovascular disease, renal, coronary and external carotid artery involvement are documented. 43% of the total group was diagnosed with hypertension, and 17% had myocardial infarctions. A total of 32% of the entire cohort had some form of chronic kidney disease, with 4% of the total group necessitating a kidney transplant. In addition, 38% had diabetes\/insulin resistance. Ages of diagnoses, treatment modalities employed, and location of vasculopathies were notated as available and applicable, as well as frequencies of other comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It is now clear that vascular disease in MOPDII is global and screening of the cardiac and renal vessels is warranted along with close monitoring of blood pressure. We recommend a blood pressure of 110\/70\u00a0mmHg as a starting point for an upper limit, especially if the individual has a history of neurovascular disease, chronic kidney disease and\/or diabetes. Additionally, providers need to be at high alert for the possibility of myocardial infarctions in young adults with MOPDII, so that appropriate treatment can be initiated promptly in an acute situation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-021-01852-y","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:09:10Z","timestamp":1621537750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Angela L.","family":"Duker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Kinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Niiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa M.","family":"Baker-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricki S.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-1264","authenticated-orcid":false,"given":"Michael B.","family":"Bober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1852_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajmg.1320120104","volume":"12","author":"F Majewski","year":"1982","unstructured":"Majewski F, Ranke M, Schinzel A. Studies of microcephalic primordial dwarfism II: the osteodysplastic type II of primordial dwarfism. Am J Med Genet. 1982;12:23\u201335.","journal-title":"Am J Med Genet"},{"key":"1852_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.a.30203","volume":"130A","author":"JG Hall","year":"2004","unstructured":"Hall JG, Flora C, Scott CI, Pauli RM, Tanaka KI. Majewski osteodysplastic primordial dwarfism type II (MOPD II): natural history and clinical findings. Am J Med Genet A. 2004;130A:55\u201372.","journal-title":"Am J Med Genet A"},{"key":"1852_CR3","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1101\/gad.169037","volume":"25","author":"A Klingseisen","year":"2011","unstructured":"Klingseisen A, Jackson AP. Mechanisms and pathways of growth failure in primordial dwarfism. Genes Dev. 2011;25:2011\u201324.","journal-title":"Genes Dev"},{"key":"1852_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.beem.2010.10.015","volume":"25","author":"A Rauch","year":"2011","unstructured":"Rauch A. The shortest of the short: pericentrin mutations and beyond. Best Pract Res Clin Endocrinol Metab. 2011;25:125\u201330.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5864","key":"1852_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1151174","volume":"319","author":"A Rauch","year":"2008","unstructured":"Rauch A, Thiel CT, Schindler D, Wick U, Crow YJ, Ekici AB, et al. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science. 2008;319(5864):816\u20139.","journal-title":"Science"},{"issue":"2","key":"1852_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ng.2007.80","volume":"40","author":"E Griffith","year":"2008","unstructured":"Griffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, Al Sanna N, Saggar A, Hamel B, Earnshaw WC, Jeggo PA, Jackson AP, O\u2019Driscoll M. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet. 2008;40(2):232\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"1852_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11914-017-0348-1","volume":"15","author":"MB Bober","year":"2017","unstructured":"Bober MB, Jackson AP. Microcephalic osteodysplastic primordial dwarfism, type II: a clinical review. Curr Osteoporos Rep. 2017;15(2):61\u20139.","journal-title":"Curr Osteoporos Rep"},{"key":"1852_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/jmg.2009.067298","volume":"47","author":"M Willems","year":"2009","unstructured":"Willems M, Genevieve D, Borck G, Baumann C, Baujat G, Bieth E, Cormier-Daire V. Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel\/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet. 2009;47:797\u2013802.","journal-title":"J Med Genet"},{"key":"1852_CR9","first-page":"925","volume":"60","author":"I Huang-Doran","year":"2011","unstructured":"Huang-Doran I, Bicknell LS, Finucane FM, Rocha N, Porter KM, Tung YC, Semple RK. Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Cells. 2011;60:925\u201335.","journal-title":"Cells"},{"key":"1852_CR10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/ajmg.a.33984","volume":"155A","author":"P Kantaputra","year":"2011","unstructured":"Kantaputra P, Tanpaiboon P, Porntaveetus T, Ohazama A, Sharpe P, Rauch A, Thiel CT. The smallest teeth in the world are caused by mutations in the PCNT gene. Am J Med Genet A. 2011;155A:1398\u2013403.","journal-title":"Am J Med Genet A"},{"key":"1852_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/BPO.0000000000000183","volume":"34","author":"AF Karatas","year":"2014","unstructured":"Karatas AF, Bober MB, Rogers K, Duker AL, Ditro CP, Mackenzie WG. Hip pathology in Majewski osteodysplastic primordial dwarfism type II. J Pediatr Orthop. 2014;34:585\u201390.","journal-title":"J Pediatr Orthop"},{"key":"1852_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ajmg.a.31009","volume":"139A","author":"F Brancati","year":"2005","unstructured":"Brancati F, Castori M, Mingarelli R, Dallapiccola B. Majewski osteodysplastic primordial dwarfism type II (MOPD II) complicated by stroke: clinical report and review of cerebral vascular anomalies. Am J Med Genet A. 2005;139A:212\u20135.","journal-title":"Am J Med Genet A"},{"key":"1852_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3171\/2009.6.PEDS08137","volume":"4","author":"JS Waldron","year":"2009","unstructured":"Waldron JS, Hetts SW, Armstrong-Wells J, Dowd CF, Fullerton HJ, Gupta N, Lawton MT. Multiple intracranial aneurysms and moyamoya disease associated with microcephalic osteodysplastic primordial dwarfism type II: surgical considerations. J Neurosurg Pediatr. 2009;4:439\u201344.","journal-title":"J Neurosurg Pediatr"},{"key":"1852_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/ajmg.a.33252","volume":"152A","author":"MB Bober","year":"2010","unstructured":"Bober MB, Khan N, Kaplan J, Lewis K, Feinstein JA, Scott CI, Steinberg GK. Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am J Med Genet A. 2010;152A:960\u20135.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"1852_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000322017","volume":"46","author":"P Moftakhar","year":"2010","unstructured":"Moftakhar P, Smith ER, Choulakian A, Scott RM, Danielpour M. Moyamoya disease in children with congenital dwarfing conditions. Pediatr Neurosurg. 2010;46(5):373\u201380.","journal-title":"Pediatr Neurosurg"},{"issue":"6","key":"1852_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3171\/2016.6.PEDS16243","volume":"25","author":"M Teo","year":"2016","unstructured":"Teo M, Johnson JN, Bell-Stephens TE, Marks MP, Do HM, Dodd RL, Bober MB, Steinberg GK. Surgical outcomes of Majewski osteodysplastic primordial dwarfism Type II with intracranial vascular anomalies. J Neurosurg Pediatr. 2016;25(6):717\u201323.","journal-title":"J Neurosurg Pediatr"},{"issue":"11","key":"1852_CR17","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1002\/ajmg.a.38467","volume":"173","author":"AL Duker","year":"2017","unstructured":"Duker AL, Niiler T, Bober MB. Expected weight gain for children with microcephalic osteodysplastic primordial dwarfism type II. Am J Med Genet A. 2017;173(11):3067\u20139.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"1852_CR18","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/ajmg.a.35447","volume":"158A","author":"MB Bober","year":"2012","unstructured":"Bober MB, Niiler T, Duker AL, Murray JE, Ketterer T, Harley ME, Alvi S, Flora C, Rustad C, Bongers EM, Bicknell LS, Wise C, Jackson AP. Growth in individuals with Majewski osteodysplastic primordial dwarfism type II caused by pericentrin mutations. Am J Med Genet A. 2012;158A(11):2719\u201325.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1852_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-2008-1038847","volume":"57","author":"J Seeburger","year":"2009","unstructured":"Seeburger J, Rastan AJ, Mohr FW. Coronary artery disease: a new manifestation in Dubowitz syndrome. Thorac Cardiovasc Surg. 2009;57(3):169\u201370.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"9","key":"1852_CR20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00431-014-2368-5","volume":"173","author":"JK Dieks","year":"2014","unstructured":"Dieks JK, Baumer A, Wilichowski E, Rauch A, Sigler M. Microcephalic osteodysplastic primordial dwarfism type II (MOPD II) with multiple vascular complications misdiagnosed as Dubowitz syndrome. Eur J Pediatr. 2014;173(9):1253\u20136.","journal-title":"Eur J Pediatr"},{"key":"1852_CR21","doi-asserted-by":"crossref","unstructured":"Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using'ggplot2'.R package version 0.4.8. 2017. https:\/\/CRAN.R-project.org\/package=survminer.","DOI":"10.32614\/CRAN.package.survminer"},{"key":"1852_CR22","unstructured":"Therneau T. A Package for Survival Analysis in R. R package version 3.2-6. 2020. https:\/\/CRAN.R-project.org\/package=survival."},{"issue":"3","key":"1852_CR23","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904.","journal-title":"Pediatrics"},{"key":"1852_CR24","doi-asserted-by":"publisher","unstructured":"Perry LD, Robertson F, Ganesan V. Screening for cerebrovascular disease in microcephalic osteodysplastic primordial dwarfism type II (MOPD II): an evidence-based proposal Pediatr Neurol. 2013;48(4):294-8. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2012.12.010.","DOI":"10.1016\/j.pediatrneurol.2012.12.010"},{"issue":"10","key":"1852_CR25","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/ajmg.a.33657","volume":"152A","author":"DM Milewicz","year":"2010","unstructured":"Milewicz DM, \u00d8stergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R, Bradley TJ, Olney AH, Ad\u00e8s L, Maher JF, Guo D, Buja LM, Kim D, Hyland JC, Regalado ES. De Novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A. 2010;152A(10):2437\u201343.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1852_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s10038-019-0626-0","volume":"64","author":"K Saida","year":"2019","unstructured":"Saida K, Kim CA, Ceroni JRM, Bertola DR, Honjo RS, Mitsuhashi S, Takata A, Mizuguchi T, Miyatake S, Miyake N, Matsumoto N. Hemorrhagic stroke and renovascular hypertension with Grange syndrome arising from a novel pathogenic variant in YY1AP1. J Hum Genet. 2019;64(9):885\u201390.","journal-title":"J Hum Genet"},{"issue":"5","key":"1852_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0883073812448531","volume":"28","author":"B Kaas","year":"2013","unstructured":"Kaas B, Huisman TAGM, Tekes A, Bergner A, Blakeley JO, Jordan LC. Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J Child Neurol. 2013;28(5):561\u20139.","journal-title":"J Child Neurol"},{"issue":"3","key":"1852_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jvs.2007.03.055","volume":"46","author":"GS Oderich","year":"2007","unstructured":"Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, Macedo TA, Stanson A. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg. 2007;46(3):475\u201384.","journal-title":"J Vasc Surg"},{"issue":"4","key":"1852_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3346\/jkms.2015.30.4.470","volume":"30","author":"TM Nam","year":"2015","unstructured":"Nam TM, Jo KI, Yeon JY, Hong SC, Kim JS. Coronary heart disease in moyamoya disease: are they concomitant or coincidence? J Korean Med Sci. 2015;30(4):470\u20134.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"1852_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ehjci\/jew006","volume":"17","author":"P Moceri","year":"2016","unstructured":"Moceri P, La\u00efk J, Bouvaist H, Fraisse A, Ferrari E. Peripheral pulmonary artery stenoses in the setting of Moyamoya. Eur Heart J Cardiovasc Imaging. 2016;17(5):575.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"1852_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.STR.31.3.733","volume":"31","author":"I Yamada","year":"2000","unstructured":"Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31(3):733\u20137.","journal-title":"Stroke"},{"issue":"1","key":"1852_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2214\/ajr.183.1.1830119","volume":"183","author":"O Togao","year":"2004","unstructured":"Togao O, Mihara F, Yoshiura T, Tanaka A, Kuwabara Y, Morioka T, Matsushima T, Sasaki T, Honda H. Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183(1):119\u201322.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1852_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejpn.2015.11.002","volume":"20","author":"JW Baek","year":"2016","unstructured":"Baek JW, Jo KI, Park JJ, Jeon P, Kim KH. Prevalence and clinical implications of renal artery stenosis in pediatric moyamoya disease. Eur J Paediatr Neurol. 2016;20(1):20\u20134.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"1852_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1463-1326.2006.00655.x","volume":"9","author":"S Rahman","year":"2007","unstructured":"Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9(6):767\u201380.","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"1852_CR35","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1852_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/aje\/kwv208","volume":"183","author":"ED Parker","year":"2016","unstructured":"Parker ED, Sinaiko AR, O\u2019Connor PJ, Ekstrom H, Appana D, Amundson J, Kharbanda EO. Potential misclassification of blood pressure status in children and adolescents with short or tall stature. Am J Epidemiol. 2016;183(1):79\u201383.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"1852_CR37","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00431-003-1310-z","volume":"162","author":"R Di Bartolomeo","year":"2003","unstructured":"Di Bartolomeo R, Polidori G, Piastra M, Viola L, Zampino G, Chiaretti A. Malignant hypertension and cerebral haemorrhage in Seckel syndrome. Eur J Pediatr. 2003;162(12):860\u20132.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"1852_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s004670050623","volume":"13","author":"JM Sorof","year":"1999","unstructured":"Sorof JM, Dow-Smith C, Moore PJ. Severe hypertensive sequelae in a child with Seckel syndrome (bird-like dwarfism). Pediatr Nephrol. 1999;13(4):343\u20136.","journal-title":"Pediatr Nephrol"},{"key":"1852_CR39","doi-asserted-by":"crossref","unstructured":"Hall JG. Re: Majewski osteodysplastic primordial dwarfism type II (MOPD II) complicated by stroke: Clinical report and review of cerebral vascular anomalies [Brancati et al.. Am J Med Genet. 2005;139A:212\u2013215]. Am J Med Genet A. 2006;140(12):1356.","DOI":"10.1002\/ajmg.a.31301"},{"issue":"12","key":"1852_CR40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u201337.","journal-title":"N Engl J Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01852-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01852-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01852-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T08:31:03Z","timestamp":1725093063000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01852-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01852-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Nemours Institutional Review Board (protocol#: 83142). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Christy Jordan, RN, BSN, is President of the Potentials Foundation, and parent of two individuals presented in this study. Angela Duker, MS, CGC and Michael Bober, MD, PhD, are on the Medical Advisory Board of the Potentials Foundation. The authors declare that there are otherwise no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}